On June 25, 2025, EYENOVIA, INC. launched a co-branded Hyperliquid validator with Kinetiq, expanding its strategy towards a cryptocurrency treasury involving Hyperliquid's native token HYPE, which has seen significant growth, ranking as the 12th-largest cryptocurrency by market cap. This strategy aims to leverage HYPE for generating revenue and supporting digital ophthalmic treatments.